Shift Work Schedule: Clinical Trials

4 trials for Shift Work Schedule, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 41Recruiting 1

Follow Shift Work Schedule: new trials by email Literature Review of Shift Work Schedule trials Research Report on Shift Work Schedule

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Metyrapone And Hydrocortisone, Dextrose, insulin - Shift Work Schedule, Circadian Rhythm
Phase 4RecruitingWashington State University482026-07-162026-09-18
The Metabolic and Circadian Effects of Shift Work
Exposure to shift work - Shift Work Schedule
CompletedTinh-Hai Collet, MD722022-02-012025-11-18
Quick Returns - Sleep, Cognitive Functions and Individual Differences
Short rest (8 hour) between two consecutive shifts., 16 hour rest opportunity between to consecutive shifts. - Shift Work Schedule, Sleep Deprivation
Not applicableCompletedUniversity of Bergen802021-09-012023-08-22
Sleep Schedule Intervention Study Among Night Shift Workers
Morning sleep schedule, Evening sleep schedule - Shift Work Schedule
Not applicableCompletedChina Medical University Hospital602019-12-172021-07-30

Narrower conditions

Diabetes Mellitus, Type 2 (1)  ·  Insulin Resistance (1)  ·  Sleep Deprivation (1)

Broader conditions

Diabetes Mellitus (1)  ·  Dyssomnias (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Sleep Wake Disorders (1)

Interventions

Glucose (1)  ·  Hydrocortisone (1)  ·  Insulin (1)  ·  Metyrapone (1)

Sponsors

China Medical University Hospital (1)  ·  Tinh-Hai Collet, MD (1)  ·  University of Bergen (1)  ·  Washington State University (1)

Countries

Norway (1)  ·  Switzerland (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Hans P.A. Van Dongen, PhD (1)  ·  Peter Liu, MBBS, PhD (1)  ·  Tinh-Hai Collet, MD (1)

Results publications

PMID 35148396, PMID 39037118, PMID 40485643

NIH funding

R01HL177106 (1)